JAMDA
July 21, 2023
Showing 1701 - 1710 of 7351 results
Caring for the Ages
September 28, 2015
Contemplating the Transitions of a ‧Poor Yorick'
JAMDA
May 16, 2020
Continuing Chronic Disease Care During COVID-19 and Beyond
JAMDA
March 6, 2024
Continuous Glucose Monitoring-Guided Insulin Administration in Long-Term Care Facilities: A Randomized Clinical Trial
To evaluate the efficacy of real-time continuous glucose monitoring (rt-CGM) in adjusting insulin therapy in long-term care facilities (LTCF).
JAMDA
December 1, 2020
Continuous Palliative Sedation in Nursing Home Residents With Dementia and Refractory Neuropsychiatric Symptoms
Extreme neuropsychiatric symptoms can be a heavy burden for nursing home (NH) residents, relatives, and caregivers. Sometimes, when extreme neuropsychiatric symptoms are considered refractory, continuous palliative sedation is administered. The aim of this study was to explore the trajectory leading to con...
JAMDA
April 27, 2021
Continuous Palliative Sedation Until Death: The Development of a Practice Protocol for Nursing Homes
Challenges inherent in the practice of continuous palliative sedation until death appear to be particularly pervasive in nursing homes. We aimed to develop a protocol to improve the quality of the practice in Belgian nursing homes.
JAMDA
May 14, 2014
Continuous Sedation Until Death With or Without the Intention to Hasten Death—A Nationwide Study in Nursing Homes in Flanders, Belgium
Continuous sedation until death (CSD), the removal of consciousness of an incurably ill patient until death, has become a controversial practice. Some consider CSD a palliative treatment, whereas others claim that CSD is frequently used with the intention to hasten death. In nursing homes in Flanders, the ...
JAMDA
March 31, 2023
Continuous Vital Signs Monitoring in Patients Hospitalized at Home: Burden or Benefit?
JAMDA
June 19, 2024
Contrast Sensitivity, Visual Field, Color Vision, Motion Perception, and Cognitive Impairment: A Systematic Review
To examine relationships between visual function (ie, contrast sensitivity, visual field, color vision, and motion perception) and cognitive impairment, including any definition of “cognitive impairment,” mild cognitive impairment, or dementia.
JAMDA
June 17, 2020